Zobrazeno 1 - 10
of 149
pro vyhledávání: ''
Autor:
Maria Letizia Petroni, Giulio Marchesini, Francesco Raimondi, Pietro Andreone, Lucia Brodosi, Ranka Vukotic, Giovanni Vitale
Publikováno v:
Annals of Internal Medicine. 173:404-405
Autor:
John McNally, Lingling Han, Paul J. Thuluvath, William J. Towner, Raymond T. Chung, Federico Hinestrosa, Ronald Nahass, David L. Wyles, Kyle Etzkorn, Diana M. Brainard, Gregory T. Everson, Timothy R. Morgan, John G. McHutchison, Myron J. Tong, M. Davis, Tram T. Tran, Brian P. Doehle, Mordechai Rabinovitz
Publikováno v:
Annals of Internal Medicine. 163:818-826
Background Effective, pangenotypic treatments for hepatitis C virus (HCV) infection are needed. Objective To assess the safety and efficacy of sofosbuvir with velpatasvir in patients infected with HCV genotypes 1 to 6. Design Randomized, phase 2, ope
Autor:
Diana M. Brainard, Simone I. Strasser, Brian P. Doehle, Gregory J. Dore, John G. McHutchison, Catherine A.M. Stedman, Steven L. Flamm, Mitchell L. Shiffman, Mordechai Rabinovitz, Edward Gane, Erik Mogalian, William J. Towner, Lingling Han, Stuart K. Roberts, Sonal Kumar, Stephen Pianko, K. Rajender Reddy, John McNally
Publikováno v:
Annals of Internal Medicine. 163:809-817
Effective treatment options are needed for patients with genotype 1 or 3 hepatitis C virus (HCV) infection in whom previous therapy has failed.To assess the efficacy and safety of sofosbuvir plus velpatasvir, with and without ribavirin, in treatment-
Autor:
Yoji, Takeuchi, Katsuhiro, Mabe, Yuichi, Shimodate, Shinji, Yoshii, Shinya, Yamada, Mineo, Iwatate, Takuji, Kawamura, Kinichi, Hotta, Koji, Nagaike, Nobuaki, Ikezawa, Tomoaki, Yamasaki, Yoriaki, Komeda, Satoshi, Asai, Yasuhiro, Abe, Takuji, Akamatsu, Yuko, Sakakibara, Hisatomo, Ikehara, Yuzuru, Kinjo, Takashi, Ohta, Yoko, Kitamura, Takashi, Shono, Takuya, Inoue, Yoshio, Ohda, Nozomu, Kobayashi, Tokuma, Tanuma, Ryu, Sato, Taku, Sakamoto, Naohiko, Harada, Akiko, Chino, Hideki, Ishikawa, Masanori, Nojima, Toshio, Uraoka, Hideki, Mori
Publikováno v:
Annals of Internal Medicine. 171:229
Background Management of anticoagulants for patients undergoing polypectomy is still controversial. Cold snare polypectomy (CSP) is reported to cause less bleeding than hot snare polypectomy (HSP). Objective To compare outcomes between continuous adm
Autor:
Robert H. Hyland, Michael Manns, Hong Liu, Benedetta Massetto, Stanislas Pol, Alessio Aghemo, John G. McHutchison, Massimo Colombo, Diana M. Brainard, Hadas Dvory-Sobol, Jie Zhang, Chohee Yun, Markus Peck-Radosavljevic, Marc Bourlière
Publikováno v:
Annals of Internal Medicine. 166:109
Background Use of interferon and ribavirin to treat chronic hepatitis C virus (HCV) infection in kidney transplant recipients is limited because of the risk for allograft rejection and poor tolerability. Objective To evaluate the safety and efficacy
Publikováno v:
Annals of Internal Medicine. 131:729-737
Among persons who receive solid organ transplants, liver transplant recipients have the highest incidence of invasive fungal infection; however, no antifungal prophylaxis has been proven to be effective.To evaluate the efficacy and safety of prophyla
Autor:
Scott McCallister, Varun Garg, N. Adda, Jürgen K. Rockstroh, Vincent Soriano, Pierre-Marie Girard, Mohammad Bsharat, Lisa Mahnke, Douglas T. Dieterich, Joshua Henshaw, Mark S. Sulkowski, Kenneth E. Sherman, Bambang S. Adiwijaya, Raymond A Rubin, Shahin Gharakhanian
Publikováno v:
Annals of Internal Medicine.
Background Telaprevir (TVR) plus peginterferon-α2a (PEG-IFN-α2a) and ribavirin substantially increases treatment efficacy for genotype 1 chronic hepatitis C virus (HCV) infection versus PEG-IFN-α2a-ribavirin alone. Its safety and efficacy in patie
Autor:
Kenneth Cusi, Fernando Bril, Paola Portillo-Sanchez, Fermin O. Tio, Joan Hecht, Romina Lomonaco, Amy Webb, Jean Hardies, Carolina Ortiz-Lopez, Beverly Orsak, Nicolas Musi, Celia Darland
Publikováno v:
Annals of Internal Medicine. 165:305
BACKGROUND The metabolic defects of nonalcoholic steatohepatitis (NASH) and prediabetes or type 2 diabetes mellitus (T2DM) seem to be specifically targeted by pioglitazone. However, information about its long-term use in this population is limited. O
Autor:
John R. Kirwan
Publikováno v:
Annals of Internal Medicine. 156:390
In this issue, Bakker and colleagues report improved outcomes for patients with early RA treated with MTX plus prednisone compared with those treated with MTX plus placebo. The editorialist notes t...
Autor:
Shana O'Roark, Saroj Vadhan-Raj, Carlos E. Bueso-Ramos, Shreyaskumar Patel, Joseph A. Ludwig, Marcella M. Johnson, Robert S. Benjamin, Xiao Zhou, Adel K. El-Naggar, Dejka M. Araujo, Ann M. Gillenwater, Jonathan C. Trent
Publikováno v:
Annals of Internal Medicine. 153:358
BACKGROUND Mucositis can be a serious complication of cancer treatment. Palifermin reduces mucositis when given in multiple doses to patients undergoing hematopoietic stem-cell transplantation. OBJECTIVE To evaluate the efficacy of palifermin given a